Evaluating the teratogenicity of the selective ß3-adrenoceptor agonist, CL 316.243 hydrate by employing FETAX (frog embryo teratogenesis assay)

References

• Ahlquist RP. (1948). A study of the adrenotropic receptors. Am J Physiol 153:586–600.
   PubMed Web of Science ®Google Scholar
• Arch JRS, Ainsworth AT, Cawthorne MA, et al. (1984). Atypical beta-adrenoceptor on brown adipocytes as target for anti-obesity drugs. Nature 309:163–165.
   PubMed Web of Science ®Google Scholar
• Arch JRS. (1989). The brown adipocyte ß-adrenoceptor. Proc Nutr Soc 48:215–223.
   PubMed Web of Science ®Google Scholar
• Arch JRS, Kaumann AJ. (1993). ß3 and atypical b-adrenoceptors. Med Res Rev 13:e663–e729.
   PubMed Web of Science ®Google Scholar
• Arch JRS. (2008). The discovery of drugs for obesity, the metabolic effects of leptin and variable receptor pharmacology: perspectives from b3-adrenoceptor agonists. Naunyn Schmiedebergs Arch Pharmacol 378:225–240.
   PubMed Web of Science ®Google Scholar
• Arch JRS. (2011). Challenges in β(3)-adrenoceptor agonist drug development . Ther Adv Endocrinol Metab 2:59–64.
   PubMedGoogle Scholar
• ASTM (American Society for Testing Materials). (2004). ASTM E1439-98. Standard guide for conducting the frog embryo teratogenesis assay-Xenopus (FETAX). In: ASTM standards on biological effects and environmental fate. Available from: http://www.astm.org/Database.Cart/Historical/E1439-98.htm.
   Google Scholar
• Bantle JA, Fort DJ, James BL. (1989). Identification of developmental toxicants using the Frog Embryo Teratogenesis Assay—Xenopus (FETAX). Hydrobiologia 188:577–585.
   Web of Science ®Google Scholar
• Bantle JA, Burton DT, Dawson DA, et al. (1994). Initial interlaboratory validation study of FETAX: phase I testing. J Appl Toxicol 14:213–223.
   PubMed Web of Science ®Google Scholar
• Bexis S, Docherty JR. (2009). Role of alpha 1- and beta 3-adrenoceptors in the modulation by SR59230A of the effects of MDMA on body temperature in the mouse. Br J Pharmacol 158:259–266.
   PubMed Web of Science ®Google Scholar
• Bhadada SV, Patel BM, Mehta AA, Goyal RK. (2011). β(3) Receptors: role in cardiometabolic disorders. Ther Adv Endocrinol Metab 2:65–79.
   PubMedGoogle Scholar
• Boga A, Binokay S, Kendirci A, et al. (2000). Morphological changes in Xenopus laevis embryos with lithium and evaluation of the FETAX test. Turkish J Biol 24:177–188.
   Google Scholar
• Boga A, Erdogan S, Sertdemir Y. (2008). Effects of specific dosages of magnesium and zinc on the teratogenicity of cadmium, nickel, and cobalt in Xenopus embryos, as assessed by the FETAX test. Dose Response 6:16–29.
   Web of Science ®Google Scholar
• Boga A, Binokay S, Sertdemir Y. (2009). The toxicity and teratogenicity of gibberellic acid (GA3) based on the frog embryo teratogenesis assay-Xenopus (FETAX). Turkish J Biol 33:181–188.
   Web of Science ®Google Scholar
• Boga A, Binokay S, Emre M, Sertdemir Y. (2012). The embryonic development of Xenopus laevis under a low frequency electric field. In Vitro Cell Dev Biol Anim 48:385–391.
   PubMed Web of Science ®Google Scholar
• Boga (Pekmezekmek) A, Binokay US, Secilmis MA, et al. (2014). Evaluating the teratogenicity of ritodrine and nifedipine using a frog embryo teratogenesis assay (FETAX). Drug Chem Toxicol 38:254–265. Early Online: 1–12. Available from: http://informahealthcare.com/dct. ISSN: 0148 -0545 (print), 1525-6014 (electronic).
   Google Scholar
• Canadian Preterm Labor Investigators Group (1992). Treatment of preterm labor with the beta-adrenergic agonist ritodrine. N Engl J Med 327:308–312.
   PubMed Web of Science ®Google Scholar
• Clément K, Vaisse C, Manning BS, et al. (1995). Genetic variation in the beta 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med 333:352–354.
   PubMed Web of Science ®Google Scholar
• Coman OA, Păunescu H, Ghiţă I, L, et al. (2009). Beta 3 adrenergic receptors: molecular, histological, functional and pharmacological approaches. Rom J Morphol Embryol 50:169–179.
   PubMed Web of Science ®Google Scholar
• Consoli D, Leggio GM, Mazzola C, et al. (2007). Behavioral effects of the β3 adrenoceptor agonist SR58611A: is it the putative prototype of a new class of antidepressant/anxiolytic drugs?. Eur J Pharmacol 573:139–147.
   PubMed Web of Science ®Google Scholar
• Dennedy CM, Friel AM, Gardeil F, Morrison JJ. (2001). Beta-3 versus beta-2 adrenergic agonists and preterm labour: in vitro uterine relaxation effects. BJOG 108:605–609.
   PubMed Web of Science ®Google Scholar
• Emorine LJ, Marullo S, Briend-Sutren MM, et al. (1989). Molecular characterization of the human beta 3-adrenergic receptor. Science 245:1118–1121.
   PubMed Web of Science ®Google Scholar
• EPA (United States Environmental Protection Agency. (2005). Science inventory. Application of frog embryo teratogenesis assay-Xenopus to ecological risk assessment. Available from: http://cfpub.epa.gov/si/si_public_record_Report.cfm?
   Google Scholar
• Ferrand C, Redonnet A, Prévot D, et al. (2006). Prolonged treatment with the beta3-adrenergic agonist CL 316243 induces adipose tissue remodeling in rat but not in guinea pig: 1) fat store depletion and desensitization of beta-adrenergic responses. J Physiol Biochem 62:89–99.
   PubMed Web of Science ®Google Scholar
• Ferrer-Lorente R, Cabot C, Fernández-López JA, Alemany M. (2005). Combined effects of oleoyl-estrone and a beta3-adrenergic agonist (CL316,243) on lipid stores of diet-induced overweight male Wistar rats. Life Sci 77:2051–2058.
   PubMed Web of Science ®Google Scholar
• Fu L, Isobe K, Zeng Q, et al. (2008). The effects of β3-adrenoceptor agonist CL-316,243 on adiponectin, adiponectin receptors and tumor necrosis factor-α expressions in adipose tissues of obese diabetic KKAy mice. Eur J Pharmacol 584:202–206.
   PubMed Web of Science ®Google Scholar
• Gauthier C, Tavernier G, Charpentier F, et al. (1996). Functional beta3-adrenoceptor in the human heart. J Clin Invest 98:556–562.
   PubMed Web of Science ®Google Scholar
• Goldenburg RL, Rouse DJ. (1998). Prevention of premature birth. N Engl J Med 339:313–320.
   PubMed Web of Science ®Google Scholar
• Hicks A, McCafferty GP, Riedel E, et al. (2007). GW427353 (solabegron), a novel, selective beta 3-adrenderic receptor agonist, evokes blad der relaxation and increases micturition reflex threshold in the dog. J Pharmacol Exp Ther 323:202–209.
   PubMed Web of Science ®Google Scholar
• How HY, Hughes SA, Vogel RL, et al. (1995). Oral terbutaline in the outpatient management of preterm labor. Am J Obstet Gynecol 173:1518–1522.
   PubMed Web of Science ®Google Scholar
• Kaya T, Karadas B, Altun A, et al. (2012). Effects and selectivity of CL 316243, beta-3-adrenoceptor agonist, in term-pregnant rat myometrium. Gynecol Obstet Invest 73:63–69.
   PubMed Web of Science ®Google Scholar
• King JF, Grant A, Keirse MJ, Chalmers I. (1988). Beta-mimetics in preterm labour: an overview of the randomized controlled trials. Br J Obstet Gynaecol 95:211–222.
   PubMedGoogle Scholar
• Larsen TM, Toubro S, van Baak MA, et al. (2002). Effect of a 28-d treatment with L-796568, a novel beta(3)-adrenergic receptor agonist, on energy expenditure and body composition in obese men. Am J Clin Nutr 76:780–788.
   PubMed Web of Science ®Google Scholar
• Li X, Zhang Y, Shi Z. (2005). Ritodrine in the treatment of preterm labour: a meta-analysis. Indian J Med Res 121:120–127.
   PubMed Web of Science ®Google Scholar
• Lindi C, Montorfano G, Rossi F, et al. (2001). Effect of ethanol exposure on Xenopus embryo lipid composition. Alcohol Alcohol 36:388–392.
   PubMed Web of Science ®Google Scholar
• Masaaki S, Hiroshi H. (2006). Recent developments in the design of orally bioavailable β3-adrenergic receptor agonists. Curr Med Chem 13:25–37.
   PubMed Web of Science ®Google Scholar
• Meier MK, Alig L, Burgi-Saville ME, Muller M. (1984). Phenylethanolamine derivatives with calorigenic and antidiabetic qualities. Int J Obes 8:215–225.
   PubMed Web of Science ®Google Scholar
• Mitchell BD, Blangero J, Comuzzie AG, et al. (1998). A paired sibling analysis of the beta-3 adrenergic receptor and obesity in Mexican Americans. J Clin Invest 101:584–587.
   PubMed Web of Science ®Google Scholar
• Morrison JJ, Rennie JM. (1997). Clinical, scientific and ethical aspects of fetal and neonatal care at extremely preterm periods of gestation. Br J Obstet Gynaecol 104:1341–1350.
   PubMedGoogle Scholar
• Morrison JJ. (2000). Preterm birth. In: Godlee F, ed. Clinical evidence. London: BMJ Publishing Group, 673–685.
   Google Scholar
• Nakatsuji N. (1983). Craniofacial malformation in Xenopus laevis tadpoles caused by the exposure of early embryos to ethanol. Teratology 28:299–305.
   PubMedGoogle Scholar
• NICEATM (The National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods). (2004). FETAX Background Review document. Executive Summary, ES1–ES16, FETAX TEST Method Protocol. Appendix 13.
   Google Scholar
• Nieuwkoop PD, Faber J. (1994). Normal table of Xenopus laevis (Daudin). Newyork & London: Garland Publishing, INC.
   Google Scholar
• Nisoli E, Tonello C, Landi M, Carruba MO. (1996). Functional studies of the first selective beta 3-adrenergic receptor antagonist SR 59230A in rat brown adipocytes. Mol Pharmacol 49:7–14.
   PubMed Web of Science ®Google Scholar
• NTP (National Toxicology Program). (2000). FETAX background review document. Frog embryo teratogenesis assay—Xenopus. Available from: http://ntp.niehs.nih.gov/go/iccvam-dev.
   Google Scholar
• Osano O, Oladimeji AA, Kraak MH, Admiraal W. (2002). Teratogenic effects of amitraz, 2,4-dimethylaniline, and paraquat on developing frog (Xenopus) embryos. Arch Environ Contam Toxicol 43:42–49.
   PubMed Web of Science ®Google Scholar
• Overstreet DH, Stemmelin J, Griebel G. (2008). Confirmation of antidepressant potential of the selective beta3 adrenoceptor agonist amibegron in an animal model of depression. Pharmacol Biochem Behav 89:623–626.
   PubMed Web of Science ®Google Scholar
• Pedzinska-Betiuk A, Modzelewska B, Kostrzewska A, Jozwik M. (2008). Influence of potent and selective beta-adrenoceptor agonist, CL 316243, on the contractile response of non-pregnant human myometrium. J Physiol Pharmacol 59:43–54.
   PubMed Web of Science ®Google Scholar
• Prati M, Biganzoli E, Boracchi P, et al. (2000). Ecotoxicological soil evaluation by FETAX. Chemosphere 41:1621–1628.
   PubMed Web of Science ®Google Scholar
• Pryde PG, Besinger RE, Gianopoulos JG, Mittendorf R. (2001). Adverse and beneficial effects of tocolytic therapy. Semin Perinatol 25:316–340.
   PubMed Web of Science ®Google Scholar
• Rodriguez M, Carillon C, Coquerel A, et al. (1995). Evidence for the presence of beta 3-adrenergic receptor mRNA in the human brain. Brain Res Mol Brain Res 29:369–375.
   PubMedGoogle Scholar
• Sennitt MV, Arch JR, Levy AL, et al. (1985). Anti-hyperglycaemic action of BRL 26830, a novel beta-adrenoceptor agonist, in mice and rats. Biochem Pharmacol 34:1279–1285.
   PubMed Web of Science ®Google Scholar
• Strosberg AD, Pietri-Rouxel F. (1996). Function and regulation of the beta 3-adrenoceptor. Trends Pharmacol Sci 17:373–381.
   PubMed Web of Science ®Google Scholar
• Takayama S, Furukawa Y, Ren LM, et al. (1993). Positive chronotropic and inotropic responses to BRL 37344, a beta 3-adrenoceptor agonist in isolated, blood-perfused dog atria. Eur J Pharmacol 231:315–321.
   PubMed Web of Science ®Google Scholar
• Takeda M, Obara K, Mizusawa T, et al. (1999). Evidence for beta3-adrenoceptor subtypes in relaxation of the human urinary bladder detrusor: analysis by molecular biological and pharmacological methods. J Pharmacol Exp Ther 288:1367–1373.
   PubMed Web of Science ®Google Scholar
• Tan S, Curtis-Prior PB. (1983). Characterization of the beta-adrenoceptor of the adipose cell of the rat. Int J Obes 7:409–414.
   PubMed Web of Science ®Google Scholar
• Tavernier G, Galitzky J, Bousquet-Melou A, et al. (1992). The positive chronotropic effect induced by BRL 37344 and CGP 12177, two beta-3 adrenergic agonists, does not involve cardiac beta adrenoceptors but baroreflex mechanisms. J Pharmacol Exp Ther 263:1083–1090.
   PubMed Web of Science ®Google Scholar
• Wheeldon NM, McDevitt DG, Lipworth BJ. (1993). Investigation of putative cardiac beta 3-adrenoceptors in man . Q J Med 86:255–261.
   PubMedGoogle Scholar
• Wheeldon NM, Newnham DM, Coutie WJ, et al. (1994). Influence of sex-steroid hormones on the regulation of lymphocyte beta 2-adrenoceptors during the menstrual cycle . Br J Clin Pharmacol 37:583–588.
   PubMed Web of Science ®Google Scholar
• Yen TT, McKee MM, Stamm NB. (1984). Thermogenesis and weight control. Int J Obes 8:65–78.
   PubMed Web of Science ®Google Scholar
• Young RC, Smith LH, McLaren MD. (1993). T-type and L-type calcium currents in freshly dispersed human uterine smooth muscle cells. Am J Obstet Gynecol 169:785–792.
   PubMed Web of Science ®Google Scholar
• Yurtcu N, Cetin A, Karadas B, et al. (2006). Comparison of effects of formoterol and BRL 37344 on isolated term-pregnant rat myometrial strips in vitro. Eur J Pharmacol 530:263–269.
   PubMed Web of Science ®Google Scholar